transplantation
Astellas is actively involved in the therapeutic community for transplantation.
Our products are globally recognized for the prevention of organ rejection after kidney, heart and liver transplantation.

Astellas remains focused on transplantation, aiming at the development of new Immunosuppressive therapies. Through support for the conduct of nearly 100 European clinical trials, we strive to improve transplantation while developing new therapies and innovative therapies that target specific biological indicators.

At the same time, we support many Patient Organizations, giving them hope for the future.

EN_Advagraf PIL | EN_Modigraf PIL | EN_PIL Prograf inf | EN_PIL Prograf caps

Learn more about our therapeutic areas:

Oncology

Through research programs, we aim to change the tomorrow of patients suffering from solid tumours, such as Prostate Cancer, and haematologic malignancies.

Urology

Focused on research to meet the needs in Benign Prostatic Hyperplasia (BPH) and Overactive Bladder Syndrome (OAB).

Transplantation

Innovative therapies for the prevention and treatment of organ rejection

Anti-infectives

We tackle the complex challenges of Fungal and Bacterial Infections

NON_2019_0011_GR

RELATED LINKS

R & D

Research and Development is at the core of everything we do. It not only drives our work today, but it fosters the work we will do tomorrow...

Read More